Our studies focus on primary prevention of HPV-related disease through vaccination, and our research group focuses on answering some of the key research questions that have emerged since the development of HPV vaccines:

  • What predicted adolescent, parent and clinician attitudes about HPV vaccines pre-licensing, and what predicts clinician recommendations and adolescent uptake of HPV vaccines post-licensing?
  • Does HPV vaccination impact sexual attitudes, behaviors and STI acquisition?
  • How will HPV vaccination impact the epidemiology of HPV in the community?
  • Is vaccination safe, immunogenic and effective in immunocompromised populations?
  • What is the feasibility of vaccination in less developed regions of the world where the burden of cervical cancer is highest, and how can we maximize vaccine delivery and uptake in these regions?